EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 160 filers reported holding EPIZYME INC in Q2 2020. The put-call ratio across all filers is 0.16 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $62,000 | -50.8% | 24,686 | 0.0% | 0.01% | -33.3% |
| Q3 2021 | $126,000 | -38.5% | 24,686 | 0.0% | 0.01% | -40.0% |
| Q2 2021 | $205,000 | -4.7% | 24,686 | 0.0% | 0.02% | -31.0% |
| Q1 2021 | $215,000 | -19.8% | 24,686 | 0.0% | 0.03% | -72.4% |
| Q4 2020 | $268,000 | -9.2% | 24,686 | 0.0% | 0.10% | -3.7% |
| Q3 2020 | $295,000 | -25.5% | 24,686 | 0.0% | 0.11% | -36.3% |
| Q2 2020 | $396,000 | +173.1% | 24,686 | +75.1% | 0.17% | +185.0% |
| Q3 2019 | $145,000 | -59.0% | 14,098 | -50.0% | 0.06% | -9.1% |
| Q2 2019 | $354,000 | +326.5% | 28,196 | +442.6% | 0.07% | +120.0% |
| Q4 2015 | $83,000 | +23.9% | 5,196 | 0.0% | 0.03% | 0.0% |
| Q3 2015 | $67,000 | -46.4% | 5,196 | 0.0% | 0.03% | -47.4% |
| Q2 2015 | $125,000 | +27.6% | 5,196 | 0.0% | 0.06% | +1.8% |
| Q1 2015 | $98,000 | 0.0% | 5,196 | 0.0% | 0.06% | +7.7% |
| Q4 2014 | $98,000 | – | 5,196 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |